A growing body of evidence suggests that the microtubule-binding protein tau is the primary hallmark of tau pathology in various neural conditions, including Alzheimer’s disease (AD) (van der Kant et al., 2020). Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.